• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期直肠癌术前放化疗联合深部区域热疗后的长期局部控制和生存率

Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer.

作者信息

Gani Cihan, Schroeder Christopher, Heinrich Vanessa, Spillner Patrick, Lamprecht Ulf, Berger Bernhard, Zips Daniel

出版信息

Int J Hyperthermia. 2016;32(2):187-92. doi: 10.3109/02656736.2015.1117661. Epub 2016 Jan 11.

DOI:10.3109/02656736.2015.1117661
PMID:26754458
Abstract

PURPOSE

The aim of this study was to evaluate the impact of deep regional hyperthermia on long-term local control and survival in locally advanced non-metastatic rectal cancer.

METHODS

In total 103 patients with locally advanced non-metastatic rectal cancer were treated preoperatively with either neoadjuvant radiochemotherapy alone (n = 43) or the same treatment with additional deep regional hyperthermia (n = 60). The two groups were compared with respect to local control, overall survival (OS), disease-free survival (DFS), and distant metastases-free survival (DMFS).

RESULTS

Patients receiving additional hyperthermia had excellent long-term local control with a 5-year Kaplan-Meier estimate of 98% compared with 87% in the radiochemotherapy only group (p = 0.09). Five-year rates for OS (88% versus 76%, p = 0.08), DFS (77% versus 73%, p = n.s.) and DMFS (75% versus 77%, p = n.s.) were not statistically different between the two groups.

CONCLUSION

Radiochemotherapy combined with hyperthermia results in excellent long-term local control.

摘要

目的

本研究旨在评估深部区域热疗对局部晚期非转移性直肠癌长期局部控制率和生存率的影响。

方法

总共103例局部晚期非转移性直肠癌患者在术前接受了单独的新辅助放化疗(n = 43)或相同治疗加深部区域热疗(n = 60)。比较两组的局部控制率、总生存期(OS)、无病生存期(DFS)和无远处转移生存期(DMFS)。

结果

接受额外热疗的患者长期局部控制效果良好,5年Kaplan-Meier估计值为98%,而仅接受放化疗的组为87%(p = 0.09)。两组的5年总生存期(88%对76%,p = 0.08)、无病生存期(77%对73%,p = 无统计学差异)和无远处转移生存期(75%对77%,p = 无统计学差异)无统计学差异。

结论

放化疗联合热疗可实现良好的长期局部控制。

相似文献

1
Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer.局部晚期直肠癌术前放化疗联合深部区域热疗后的长期局部控制和生存率
Int J Hyperthermia. 2016;32(2):187-92. doi: 10.3109/02656736.2015.1117661. Epub 2016 Jan 11.
2
Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone.新辅助放化疗联合区域热疗对比单纯放化疗治疗局部进展期直肠癌的病理完全缓解和保肛手术。
Int J Hyperthermia. 2012;28(8):707-14. doi: 10.3109/02656736.2012.722263. Epub 2012 Sep 24.
3
External validation of a rectal cancer outcome prediction model with a cohort of patients treated with preoperative radiochemotherapy and deep regional hyperthermia.术前放化疗联合深部区域热疗治疗直肠癌患者队列的直肠癌预后预测模型的外部验证。
Int J Hyperthermia. 2018 Jun;34(4):455-460. doi: 10.1080/02656736.2017.1338364. Epub 2017 Jul 26.
4
Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.术前采用卡培他滨和顺铂同期放化疗治疗磁共振成像定义的局部进展期直肠癌:对长期临床结局的影响。
J Clin Oncol. 2011 Mar 10;29(8):1042-9. doi: 10.1200/JCO.2010.29.7697. Epub 2011 Jan 24.
5
Clinical outcomes of mild hyperthermia for locally advanced rectal cancer treated with preoperative radiochemotherapy.术前放化疗联合轻度热疗治疗局部进展期直肠癌的临床疗效。
Int J Hyperthermia. 2011;27(5):482-90. doi: 10.3109/02656736.2011.563769.
6
Deep regional hyperthermia with preoperative radiochemotherapy in locally advanced rectal cancer, a prospective phase II trial.局部进展期直肠癌术前放化疗联合深部区域热疗的前瞻性Ⅱ期临床研究。
Radiother Oncol. 2021 Jun;159:155-160. doi: 10.1016/j.radonc.2021.03.011. Epub 2021 Mar 17.
7
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.奥沙利铂联合氟尿嘧啶为基础的术前放化疗和局部进展期直肠癌术后化疗(德国 CAO/ARO/AIO-04 研究):多中心、开放标签、随机、III 期临床试验的最终结果。
Lancet Oncol. 2015 Aug;16(8):979-89. doi: 10.1016/S1470-2045(15)00159-X. Epub 2015 Jul 15.
8
[Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].术前放疗或放化疗在局部进展期低位直肠癌保肛中的应用评估
Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):225-7.
9
Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.术前放化疗可提高局部晚期直肠癌的无局部复发生存率。
J BUON. 2013 Apr-Jun;18(2):385-90.
10
Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy.18F-FDG PET对先前接受新辅助放化疗的局部晚期直肠癌患者的长期预后价值
AJR Am J Roentgenol. 2006 Aug;187(2):W202-8. doi: 10.2214/AJR.05.0902.

引用本文的文献

1
Hounsfield unit change in metastatic abdominal lymph nodes treated with combined hyperthermia and radiotherapy.热疗联合放疗治疗转移性腹部淋巴结的亨氏单位变化
PLoS One. 2025 Mar 25;20(3):e0318330. doi: 10.1371/journal.pone.0318330. eCollection 2025.
2
Neoadjuvant chemoradiotherapy in combination with deep regional hyperthermia followed by surgery for rectal cancer: a systematic review and meta-analysis.新辅助放化疗联合深部区域热疗后手术治疗直肠癌:一项系统评价和荟萃分析。
Strahlenther Onkol. 2025 Feb;201(2):151-162. doi: 10.1007/s00066-024-02312-9. Epub 2024 Oct 17.
3
Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer.
基于 CT 模拟的放射组学预测局部晚期直肠癌新辅助放化疗后疗效。
Radiat Oncol. 2022 Apr 28;17(1):84. doi: 10.1186/s13014-022-02053-y.
4
Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer.基于13.56兆赫兹调制的电热疗法的术前热放化疗在局部晚期直肠癌中的长期可行性
Cancers (Basel). 2022 Mar 1;14(5):1271. doi: 10.3390/cancers14051271.
5
Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas.局部晚期和复发性直肠腺癌术前放化疗联合区域热疗的II期研究长期结果
Cancers (Basel). 2022 Jan 29;14(3):705. doi: 10.3390/cancers14030705.
6
Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment.用于指导热疗治疗的温度测量参数的临床证据。
Cancers (Basel). 2022 Jan 26;14(3):625. doi: 10.3390/cancers14030625.
7
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer.新辅助放化疗联合区域热疗治疗局部晚期或复发性直肠癌
Cancers (Basel). 2021 Mar 13;13(6):1279. doi: 10.3390/cancers13061279.
8
1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation.1.5T磁共振直线加速器计划研究以比较两种不同的直肠后装放疗策略。
Clin Transl Radiat Oncol. 2020 Dec 3;26:86-91. doi: 10.1016/j.ctro.2020.11.016. eCollection 2021 Jan.
9
A Narrative Review of Regional Hyperthermia: Updates From 2010 to 2019.区域热疗的叙述性综述:2010 年至 2019 年的更新。
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420932648. doi: 10.1177/1534735420932648.
10
The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors.高热在恶性肿瘤多学科治疗中的作用。
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419876345. doi: 10.1177/1534735419876345.